Is valvular calcification a part of the missing link between residual kidney function and cardiac hypertrophy in peritoneal dialysis patients?

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 10, 2009, Pages 1629-1636

  Wang, Angela Yee Moon ^a,c   Lam, Christopher Wai Kei ^a,b   Wang, Mei ^a,c   Chan, Iris Hiu Shuen ^a   Lui, Siu Fai ^a   Sanderson, John E ^a,d  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; PHOSPHORUS;

ADULT; ARTICLE; BLOOD VESSEL CALCIFICATION; CREATININE CLEARANCE; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DISEASE EXACERBATION; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE UROPATHY; PERITONEAL DIALYSIS; PREVALENCE; PROTEIN BLOOD LEVEL; RENOVASCULAR HYPERTENSION; RISK FACTOR; RISK REDUCTION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; URINALYSIS;

ADULT; AGED; C-REACTIVE PROTEIN; CALCINOSIS; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HEART VALVE DISEASES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LINEAR MODELS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS;

EID: 73349126112     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03100509     Document Type: Article

References (34)

1. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47: 186-192, 1995
2. Harnett JD, Kent GM, Barre PE, Taylor R, Parfrey PS: Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 4: 1486-1490, 1994
3. Enia G, Mallamaci F, Benedetto FA, Panuccio V, Parlongo S, Cutrupi S, Giacone G, Cottini E, Tripepi G, Malatino LS, Zoccali C: Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant 16: 1459-1464, 2001
4. Wang AY, Wang M, Woo J, Law MC, Chow KM, Li PK, Lui SF, Sanderson JE: A novel association between the degree of residual renal function and severity of left ventricular hypertrophy in end-stage renal failure patients undergoing long-term peritoneal dialysis. Kidney Int 62: 639-647, 2002
5. Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE: Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 12: 1927-1936, 2001
6. Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, Sanderson JE: Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study. J Am Soc Nephrol 13: 159-168, 2003
7. Wang AY, Woo J, Lam CK, Wang M, Sea MM, Lui SF, Li PK, Sanderson J: Is a single time-point c-reactive protein predictive of outcome in peritoneal dialysis patients? J Am Soc Nephrol 14: 1871-1879, 2003
8. Kim SB, Min WK, Lee SK, Park JS, Hong CD, Yang WS: Persistent elevation of C-reactive protein and ischemic heart disease in patients with continuous ambulatory peritoneal dialysis. Am J Kidney Dis 39: 342-346, 2002
9. Wang AY, Wang M, Woo J, Lam CW, Lui SF, Li PK, Sanderson JE: Inflammation, residual kidney function and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 15: 2186-2194, 2004
10. Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Giovannini L, Norpoth M, Metelli MR, Cristofani R, Bertelli AA, Sbragia G, Tetta C, Palla R, Colombo R: C-reactive protein and interleukin-6 levels are related to renal function in pre-dialytic chronic renal failure. Nephron 91: 594-600, 2002
11. Chung SH, Heimburger O, Stenvinkel P, Bergstrom J, Lindholm B: Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant 16: 2240-2245, 2001
12. Bemelmans MH, Gouma DJ, Buurman WA: Influence of nephrectomy on tumor necrosis factor clearance in a murine model. J Immunol 150: 2007-2017, 1993
13. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, et al.: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 2: 358-367, 1989
14. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH: Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25: 1056-1062, 1995
15. Garcia MJ, Thomas JD, Klein AL: New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 32: 865-875, 1998
16. Wong M, Tei C, Shah PM: Sensitivity and specificity of two-dimensional echocardiography in the detection of valvular calcification. Chest 84: 423-427, 1983
17. Otto CM: Textbook of Clinical Echocardiography, 2nd Ed., Philadelphia, WB Saunders, 2000, pp 229-264
18. van Olden RW, Krediet RT, Struijk DG, Arisz L: Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 7: 745-750, 1996
19. Nolph KD, Moore HL, Twardowski ZJ, Khanna R, Prowant B, Meyer M, Ponferrada L: Cross-sectional assessment of weekly urea and creatinine clearances in patients on continuous ambulatory peritoneal dialysis. ASAIO J 38: M139-M142, 1992
20. Wang AY, Woo J, Sea MM, Law MC, Lui SF, Li PK: Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: What are the implications? Am J Kidney Dis 43: 712-720, 2004
21. Ventura JE, Tavella N, Romero C, Petraglia A, Baez A, Munoz L: Aortic valve calcification is an independent factor of left ventricular hypertrophy in patients on maintenance hemodialysis. Nephrol Dial Transplant 17: 1795-1801, 2002
22. Ansari A, Kaupke CJ, Vaziri ND, Miller R, Barbari A: Cardiac pathology in patients with end-stage renal disease maintained in hemodialysis. Int J Artif Organs 16: 31-36, 1993
23. Kuzela DC, Huffer WE, Conger JD, Winter SD, Hammond WS: Soft tissue calcification in chronic dialysis patients. Am J Pathol 86: 403-424, 1977
24. Mall G, Hunther W, Schneider J, Lundin P, Ritz E: Diffuse intermyocardiocytic fibrosis in uremic patients. Nephrol Dial Transplant 5: 39-44, 1990
25. Rostand SG, Sanders C, Kirk KA, Rutsky EA, Fraser RG: Myocardial calcification and cardiac dysfunction in chronic renal failure. Am J Med 85: 651-657, 1988
26. Amann K, Tornig J, Kugel B: Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney Int 63: 1296-1301, 2003
27. Guerin AP, London GM, Marchais SJ, Metivier F: Arterial stiffening and vascular calcifications in end stage renal disease. Nephrol Dial Transplant 15: 1014-1021, 2000
28. London GM, Guerin AP: Influence of arterial pulse and reflected waves on blood pressure and cardiac function. Am Heart J 138: 220-224, 1999
29. Salgueira M, del Toro N, Moreno-Alba R, Jimenez E, Areste N, Palma A: Vascular calcification in the uremic patient: A cardiovascular risk? Kidney Int Suppl 85: S119-S121, 2003
30. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27: 394-401, 1996
31. Moe SM, Chen NX: Inflammation and vascular calcification. Blood Purif 3: 64-71, 2005
32. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJ, Anker SD: Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 353: 1838-1842, 1999
33. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, Bosselmann HP, Heimbürger O, Simonsen O, Davenport A, Tranaeus A, Divino Filho JC: Icodextrin improves the fluid status of peritoneal dialysis patients: Results of a double-blind randomized controlled trial. J Am Soc Nephrol 14: 2338-2344, 2003
34. Harnett JD, Parfrey PS, Griffiths SM, Gault MH, Barre P, Guttmann RD: Left ventricular hypertrophy in end-stage renal disease. Nephron 48: 107-115, 1988